Kaira K - Search Results

1

Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.

Kaira K, Okumura T, Ohde Y, Takahashi T, Murakami H, Oriuchi N, Endo M, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. J Nucl Med. 2011 May;52(5):705-11. doi: 10.2967/jnumed.111.087676. Epub 2011 Apr 15. J Nucl Med. 2011. PMID: 21498541 Free article.

2

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis.

Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Hisada T, Mori M. Kaira K, et al. Clin Nucl Med. 2007 Feb;32(2):114-6. doi: 10.1097/01.rlu.0000252216.68848.d7. Clin Nucl Med. 2007. PMID: 17242564 No abstract available.

3

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.

Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Endo K, Mori M. Kaira K, et al. Chest. 2007 Apr;131(4):1019-27. doi: 10.1378/chest.06-2160. Chest. 2007. PMID: 17426205

4

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.

Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Ishizuka T, Saito R, Nakajima T, Mori M. Kaira K, et al. Int J Oncol. 2007 Jul;31(1):169-73. Int J Oncol. 2007. PMID: 17549418

5

Rapid growth of malignant pleural mesothelioma.

Kaira K, Dobashi K, Yanagitani N, Sunaga N, Shimizu Y, Hisada T, Ishizuka T, Nakajima T, Mori M. Kaira K, et al. J Thorac Oncol. 2007 Oct;2(10):966-7. doi: 10.1097/JTO.0b013e31811f474e. J Thorac Oncol. 2007. PMID: 17909361 Free article. No abstract available.

6

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer.

Sunaga N, Oriuchi N, Kaira K, Yanagitani N, Tomizawa Y, Hisada T, Ishizuka T, Endo K, Mori M. Sunaga N, et al. Among authors: kaira k. Lung Cancer. 2008 Feb;59(2):203-10. doi: 10.1016/j.lungcan.2007.08.012. Epub 2007 Oct 25. Lung Cancer. 2008. PMID: 17913282

7

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.

Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Dobashi K, Kanai Y, Endou H, Nakajima T, Endo K, Mori M. Kaira K, et al. Clin Cancer Res. 2007 Nov 1;13(21):6369-78. doi: 10.1158/1078-0432.CCR-07-1294. Clin Cancer Res. 2007. PMID: 17975149

8

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. Kaira K, et al. Br J Cancer. 2008 Feb 26;98(4):742-8. doi: 10.1038/sj.bjc.6604235. Epub 2008 Feb 5. Br J Cancer. 2008. PMID: 18253116 Free PMC article.

9

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Iijima H, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. Kaira K, et al. Pathol Res Pract. 2008;204(8):553-61. doi: 10.1016/j.prp.2008.02.003. Epub 2008 Apr 28. Pathol Res Pract. 2008. PMID: 18440724

10

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. Kaira K, et al. Cancer Sci. 2008 Dec;99(12):2380-6. doi: 10.1111/j.1349-7006.2008.00969.x. Epub 2008 Nov 17. Cancer Sci. 2008. PMID: 19018776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters